Pyridine derivatives as S1P1/EDG1 receptor modulators

Details for Australian Patent Application No. 2008290233 (hide)

Owner ACTELION PHARMACEUTICALS LTD

Inventors Mathys, Boris; Mueller, Claus; Steiner, Beat; Nayler, Oliver; Lescop, Cyrille; Velker, Jorg; Bolli, Martin

Agent A J Park

Pub. Number AU-A-2008290233

PCT Pub. Number WO2009/024905

Priority PCT/ IB2007/053293 17.08.07 IB

Filing date 14 August 2008

Wipo publication date 26 February 2009

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/024905 Priority application(s): WO2009/024905

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008290234-4-pyrimidinesulfamide derivative

2008290220-Pyrimidine and pyridine derivatives as POSH and POSH-AP inhibitors